Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,280.90 -26.25 -0.17%
S&P 500 1,649.92 -5.43 -0.33%
Nasdaq 3,455.42 -7.88 -0.23%
Ticker Volume Price Price Delta
STOXX 50 2,776.78 -58.23 -2.05%
FTSE 100 6,696.79 -143.48 -2.10%
DAX 8,351.98 -178.91 -2.10%
Ticker Volume Price Price Delta
Nikkei 14,484.00 -1,143.28 -7.32%
Hang Seng 22,669.70 -591.40 -2.54%
S&P/ASX 200 5,062.45 -102.92 -1.99%
  • Exchange: RTS
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

ORGN*:RU

Snapshot for Organica JSC (ORGN*)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for ORGN*

No chart data available.
  • ORGN*:RU
  • 1M
  • 1Y
0.0000
Interactive ORGN* Chart

Previous Close

Key Statistics for ORGN*

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. RTSI$ -
Earnings Per Share (ttm) 39.4856
Est. EPS -
Est. PEG Ratio -
Market Cap (M RUB) 0.00
Shares Outstanding (M) 0.15
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Last Dividend
5 Year Dividend Growth -
Next Earnings Announcement 08/02/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORGN*

  • Revenue
  • Net Income (M/RUB)
  • Profit Margin (%)

Company Profile & Key Executives for ORGN*

Organica JSC manufactures and markets a variety of medicines. The Company's products include painkillers, tranquilizers, antibiotics, vitamins, and other pharmaceuticals.

Andrey Petrovich LyangusGeneral DirectorNatalia Sergeevna KambalinaChief Accountant
Viktor Vladimirovich AbramovDeputy Chief AccountantVladimir Mikhailovich AbramovExecutive Director
More Company Profile & Key Executives for ORGN*

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil